Delivery Order SPE2DR25D3505-SPE2DR26F93C1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,273.37 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units) on September 9, 2025, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation reflects a routine pharmaceutical procurement fulfilling military healthcare supply requirements. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,779.46 to AmerisourceBergen Drug Corp for Januvia 100 mg tablets (90-count supply) on August 8, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed price, non-set-aside contract for delivery to the vendor's corporate headquarters location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal pharmaceutical supply relationship with...
- The Defense Logistics Agency awarded a delivery order valued at $36,390.38 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on July 25, 2025, with completion scheduled for July 28, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to the prime contractor. The pharmaceutical product will be delivered to the company's place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,091.46 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units) under a firm fixed price contract type. The award was made on October 20, 2025, with an ultimate completion date of October 21, 2025, and reflects a competitively awarded, non-set-aside procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $21,645.40 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, with an ultimate completion date of October 31, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a continuation of pharmaceutical supply services to federal healthcare systems. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Januvia 100 mg tablets (90-count units) with a ceiling value of $1,761.10. This non-competitive, firm fixed-price delivery order is scheduled for completion by November 14, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's substantial role as a pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,413.42 for Januvia 50 mg tablets (90-count units) on October 15, 2025, with completion expected by October 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a competitively bid delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Januvia 100 mg tablets (90-count units) at a ceiling value of $16,310.52. This firm fixed-price delivery order, effective through November 5, 2025, represents a continuation of the prime contractor's role as a critical pharmaceutical supplier within the federal medical supply chain. The award was issued under a non-set-aside competitive procurement process...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Januvia 100 mg tablets (90-count units) under a firm fixed-price contract valued at $1,091.46. This is a non-set-aside competitive award with an ultimate completion date of September 23, 2025, to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents pharmaceutical procurement to support federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $11,738.09 to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, a diabetes medication. The contract is firm fixed price with an ultimate completion date of November 17, 2025, and was awarded on November 14, 2025 with no set-aside designation. Performance will occur at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DR25D3505Indefinite Delivery Contract
- SPE2DR25D3505-SPE2DR26F93C1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,373.55 to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Januvia 100 mg tablets (90-count packages). This is a firm fixed price delivery order with an ultimate completion date of November 14, 2025, and represents a non-competitive set-aside award. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor supporting federal medical procurement needs. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC, designated SPE2DX, serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's demonstrated capability to fulfill federal pharmaceutical requirements through open competition, combined with its extensive portfolio of medical product deliveries across multiple therapeutic domains, positions it as a critical vendor for Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 11/13/25 |